Mediceo Paltac Holdings Co
Mediceo Paltac Holdings Co., a prominent player in the pharmaceutical and healthcare distribution industry, is headquartered in Japan. Established in 1948, the company has evolved significantly, expanding its operational reach across major regions in Asia. Specialising in the distribution of pharmaceuticals, medical devices, and healthcare products, Mediceo Paltac is recognised for its commitment to quality and innovation. The company’s core offerings include a diverse range of medical supplies and consumer health products, distinguished by their reliability and adherence to stringent safety standards. With a strong market position, Mediceo Paltac Holdings has achieved notable milestones, including strategic partnerships and a robust supply chain network, solidifying its reputation as a trusted distributor in the healthcare sector.
DitchCarbon Score
How does Mediceo Paltac Holdings Co's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Mediceo Paltac Holdings Co's score of 17 is higher than 81% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Mediceo Paltac Holdings Co's reported carbon emissions
In 2023, Mediceo Paltac Holdings Co reported total carbon emissions of approximately 14,255,621,000 kg CO2e. This figure includes emissions across all three scopes: Scope 1 emissions were about 28,439,000 kg CO2e, Scope 2 emissions totalled approximately 46,552,000 kg CO2e, and Scope 3 emissions reached about 14,255,621,000 kg CO2e. Notably, the Scope 3 emissions are significantly higher, indicating a substantial impact from upstream and downstream activities, particularly from purchased goods and services, which accounted for about 13,426,666,000 kg CO2e. Mediceo Paltac has not disclosed specific reduction targets or initiatives as part of their climate commitments. The absence of documented reduction targets suggests that while the company is aware of its emissions profile, it may not yet have formalised a strategy for emissions reduction or climate pledges. This context highlights the importance of ongoing efforts within the industry to address climate change and improve sustainability practices.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Scope 1 | 32,573,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 49,959,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | 00,000,000 | 00,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Mediceo Paltac Holdings Co is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
